ARTG 462525Clinical chemistry-specific protein IVDs
ARTG ID: 462525 · Beckman Coulter Australia Pty Ltd · Immunotech SAS a Beckman Coulter Company · Class IIb · Started September 23, 2024
Good Name: Beckman Coulter Australia Pty Ltd - Clinical chemistry-specific protein IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- ARTG ID
- 462525
- Start Date
- September 23, 2024
- Effective Date
- September 23, 2024
- Country
- France
- Address
- 130 Avenue de Lattre de Tassigny BP177, Marseille, Cedex 9, 13276
IVDs that are paramagnetic particle, chemiluminescent immunoassays used for the qualitative and/or quantitative determination of proteins specific to clinical chemistry in human serum and plasma using the automated DxI Access Immunoassay Analyzers.
Access comprehensive regulatory information for Clinical chemistry-specific protein IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 462525 and sponsored by Beckman Coulter Australia Pty Ltd, manufactured by Immunotech SAS a Beckman Coulter Company in France. The device registration started on September 23, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.